Health ❯ Healthcare ❯ Medical Research ❯ Cancer Treatment

Breast Cancer

GLP-1 Drugs Linked to Better Breast Cancer Survival in Large EHR Study

The analysis of health records cannot show the drugs caused the gains.

Phase II Trial Finds 24 Gy Preoperative Radiation With Pembrolizumab Boosts T‑Cell Infiltration in HR+/HER2− Breast Cancer

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

Roche Says Breast Cancer Pill Cuts Recurrence in Phase 3 Adjuvant Trial

BioNTech Breast Cancer ADC Meets Phase 3 Goal in China Interim Analysis

New Triple-Drug Regimen Boosts Survival in PIK3CA-Mutant HR+ HER2- Breast Cancer

Arvinas’ Vepdegestrant Delays Breast Cancer Progression Longer Than Faslodex

Breast Cancer Trial Achieves 100% Survival with Pre-Surgery Olaparib